The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density ...

Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 trial R ...

Recent Clinical Progress, Enrollment Achievements, Expanded Intellectual Property Portfolio and Strengthened Financial Position Support a Potentially Transformative 12-Month Value Creation Opportunity ...

CEO Thomas Equels discusses recent clinical progress, upcoming milestones and the Company's commitment to advancing Ampligen® for patients with pancreatic cancer ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Today is Wednesday, July 8, and welcome to the Butler National Corporation Conference Call. [Operator Instructions] Your call leaders for today's call are Jeffrey D. Yowell, Executive Chairman; Adam ...

From life sciences, food processing and hospitality to sports, architecture and agriculture, business organizations in the ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the 26-week results (Part B) from its second ongoing ...

After losing civil service protections, some federal employees now in Schedule Policy/Career fear for their job security and ...

AI compressed the build. Fundamentals matter more, not less, and the product funnel is now where engineers earn their keep.

Volkswagen seeks to simplify its model portfolio, reduce variants, optimize its global production network, centralize key ...

Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...